Incretin-Pathway Peptides
Cagrilintide
An acylated amylin analogue supplied as a sealed lyophilized vial for receptor-pharmacology and stability research.
5mg · 10mg · 20mg
View Details
Incretin-Pathway Peptides
A two-component blend of cagrilintide and semaglutide, sealed as a lyophilized vial for comparative signaling research.
Research use only
CagriSema combines the amylin analogue cagrilintide with the GLP-1 analogue semaglutide in a single lyophilized vial. As a two-peptide blend, this entry does not carry a single CAS number or molecular weight; the composition for a given batch is described in that batch's documentation.
This combination is referenced in controlled in-vitro research for comparative signaling studies across the two component pathways, and for analytical work assessing how the two peptides behave when prepared together.
The vial is sealed after freeze-drying and offered at the total nominal masses listed under available sizes, from 5mg through 20mg.
| Purity | ≥99% by HPLC |
|---|---|
| CAS number | See batch documentation |
| Molecular weight | See batch documentation |
| Molecular formula | See batch documentation |
| Material class | Two-component peptide blend |
| Appearance | White to off-white lyophilized powder |
| Available vial sizes | 5mg total · 10mg total · 20mg total |
| Documentation | Batch documentation confirmed on request |